Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Patients with HR+/HER2- advanced breast cancer commonly experience fatigue, hair loss, and pain, which significantly affect daily activities.

Madarosis (eyebrow and eyelash loss) significantly affects quality of life for breast cancer patients on taxane-based chemotherapy.

Honey and bee pollen can help reduce menopausal symptoms in breast cancer patients.

Cinobufacin with chemotherapy improves treatment response and quality of life in advanced breast cancer patients while reducing some side effects.

Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.

Oral dutasteride, minoxidil, and finasteride may help reduce hair loss in breast cancer survivors, but more research is needed.

Severe COVID-19 may increase lung cancer risk and affect treatment in women due to hormonal changes.

MVP treatment is effective and safe for recurrent breast cancer.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

Compounds from Etlingera alba may help treat Triple Negative Breast Cancer.

Increased EGFR gene variations may predict chemotherapy outcomes in small cell lung cancer patients.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

Palbociclib generally maintains or improves quality of life in advanced breast cancer patients.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Chemotherapy reduces taste and smell, but they mostly recover after treatment; adding spices may help improve appetite.

New CRISPR/Cas9 variants and nanotechnology-based delivery methods are improving cancer treatment, but choosing the best variant and overcoming certain limitations remain challenges.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

PRP may increase hair density but doesn't improve quality of life in breast cancer survivors with hair loss.

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

Reporter characteristics affect detection of hair loss from cancer therapy.

The type of tumor suppressor gene lost affects the behavior of skin cancer.

A man with myotonic dystrophy type 1 had 28 skin cancers, suggesting a link between the disease and skin cancer, emphasizing the need for sun protection and regular skin checks.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.